← CROSS COUNTRY HEALTHCARE INC CCRN
Market Price
$13.26
Market Cap
$411.17M
P/E Ratio
N/A
Revenue (FY 2025)
↓-21.6% YoY
$1.05B
3-Yr CAGR: -27.8%
Net Income
↓-551.6% YoY
-$94.85M
Net Margin: -9.0%
Free Cash Flow
↓-64.0% YoY
$40.09M
FCF Yield: 9.75%
EPS (Diluted)
↓-565.9% YoY
$-2.93
Basic: $-2.93
Return on Equity
Efficiency
-29.4%
ROA: -32.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CCRN)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $192.1M | — | $186.0M | $8.0M | — | $0.15 | — | $30.1M | $23.6M | — |
| FY 2017 | $203.4M | +5.9% | $199.2M | $37.5M | +370.9% | $1.01 | +573.3% | $45.5M | $40.4M | +71.0% |
| FY 2018 | $816.5M | +301.4% | $810.8M | $-17.0M | -145.2% | $-0.48 | -147.5% | $21.0M | $16.4M | -59.4% |
| FY 2019 | $822.2M | +0.7% | $816.9M | $-57.7M | -240.5% | $-1.61 | -235.4% | $5.5M | $2.6M | -84.1% |
| FY 2020 | $836.4M | +1.7% | $833.5M | $-13.0M | +77.5% | $-0.36 | +77.6% | $27.2M | $22.6M | +768.1% |
| FY 2021 | $1,676.7M | +100.5% | $1,669.8M | $132.0M | +1,118.4% | $3.53 | +1,080.6% | $-85.6M | $-92.8M | -510.8% |
| FY 2022 | $2,806.6M | +67.4% | $2,792.2M | $188.5M | +42.8% | $5.02 | +42.2% | $134.1M | $125.3M | +235.0% |
| FY 2023 | $2,019.7M | -28.0% | $2,011.6M | $72.6M | -61.5% | $2.05 | -59.2% | $248.5M | $234.5M | +87.2% |
| FY 2024 | $1,344.0M | -33.5% | $1,341.8M | $-14.6M | -120.0% | $-0.44 | -121.5% | $120.1M | $111.4M | -52.5% |
| FY 2025 | $1,054.3M | -21.6% | $1,052.1M | $-94.9M | -551.6% | $-2.93 | -565.9% | $48.3M | $40.1M | -64.0% |
Valuation
Market Price
$13.26
Market Cap
$411.17M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
1.27
FCF Yield
9.75%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
99.79%
Operating Margin
-8.01%
Net Margin
-9.00%
Return on Equity (ROE)
-29.38%
Return on Assets (ROA)
-32.31%
Asset Turnover
3.59x
Revenue 3-Yr CAGR
-27.85%
Financial Health & Liquidity
Current Ratio
11.91
Cash Ratio
4.41
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$108.74M
Total Debt
N/A
Book Value / Share
$10.41
Cash Flow Efficiency
Operating Cash Flow
$48.25M
Capital Expenditures (CapEx)
$8.16M
Free Cash Flow
$40.09M
OCF / Revenue
4.58%
FCF / Revenue
3.80%
FCF 3-Yr CAGR
-31.60%
Per Share Metrics
EPS (Diluted)
$-2.93
EPS (Basic)
$-2.93
Dividends / Share
N/A
Book Value / Share
$10.41
EPS YoY Growth
-565.91%
Balance Sheet (FY 2025)
Total Assets
$293.59M
Total Liabilities
$24.65M
Stockholders' Equity
$322.82M
Current Assets
$293.59M
Current Liabilities
$24.65M